The systemic nature of CKD

Key Points CKD is an inherently systemic disease Energy balance, innate immunity and neuroendocrine control of organ function are highly integrated biological processes; such integration is disrupted by loss of kidney function, which generates a high risk clinical phenotype The clinical profile of c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature reviews. Nephrology 2017-06, Vol.13 (6), p.344-358
Hauptverfasser: Zoccali, Carmine, Vanholder, Raymond, Massy, Ziad A., Ortiz, Alberto, Sarafidis, Pantelis, Dekker, Friedo W., Fliser, Danilo, Fouque, Denis, Heine, Gunnar H., Jager, Kitty J., Kanbay, Mehmet, Mallamaci, Francesca, Parati, Gianfranco, Rossignol, Patrick, Wiecek, Andrzej, London, Gerard
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 358
container_issue 6
container_start_page 344
container_title Nature reviews. Nephrology
container_volume 13
creator Zoccali, Carmine
Vanholder, Raymond
Massy, Ziad A.
Ortiz, Alberto
Sarafidis, Pantelis
Dekker, Friedo W.
Fliser, Danilo
Fouque, Denis
Heine, Gunnar H.
Jager, Kitty J.
Kanbay, Mehmet
Mallamaci, Francesca
Parati, Gianfranco
Rossignol, Patrick
Wiecek, Andrzej
London, Gerard
description Key Points CKD is an inherently systemic disease Energy balance, innate immunity and neuroendocrine control of organ function are highly integrated biological processes; such integration is disrupted by loss of kidney function, which generates a high risk clinical phenotype The clinical profile of chronic kidney disease (CKD) includes inflammation, malnutrition, altered activity of the autonomic and central nervous systems, and cardiopulmonary, vascular and bone disease The gut and the lung are emerging as critical mediators of the interaction between the kidney and the environment, and are involved in cardiovascular disease and other systemic complications of CKD Alterations in macrovascular and microvascular function induced by sleep apnoea, inflammation and oxidative stress increase the risk of brain disease in CKD The application of omics sciences will enable in-depth studies of the pathophysiology and treatment of CKD Chronic kidney disease (CKD) affects numerous organs and systems, which in turn have effects on kidney function. This Review provides an overview of CKD as a systemic disease and discusses the multidirectional links between the kidney, bone, nervous and immune systems, and metabolism. The accurate definition and staging of chronic kidney disease (CKD) is one of the major achievements of modern nephrology. Intensive research is now being undertaken to unravel the risk factors and pathophysiologic underpinnings of this disease. In particular, the relationships between the kidney and other organs have been comprehensively investigated in experimental and clinical studies in the last two decades. Owing to technological and analytical limitations, these links have been studied with a reductionist approach focusing on two organs at a time, such as the heart and the kidney or the bone and the kidney. Here, we discuss studies that highlight the complex and systemic nature of CKD. Energy balance, innate immunity and neuroendocrine signalling are highly integrated biological phenomena. The diseased kidney disrupts such integration and generates a high-risk phenotype with a clinical profile encompassing inflammation, protein–energy wasting, altered function of the autonomic and central nervous systems and cardiopulmonary, vascular and bone diseases. A systems biology approach to CKD using omics techniques will hopefully enable in-depth study of the pathophysiology of this systemic disease, and has the potential to unravel critical pathways that can
doi_str_mv 10.1038/nrneph.2017.52
format Article
fullrecord <record><control><sourceid>gale_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_01848408v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A491832070</galeid><sourcerecordid>A491832070</sourcerecordid><originalsourceid>FETCH-LOGICAL-c563t-e39d1a093599d39426775416ddf0e1cd9e93176d172a00d069734fa440c50bf43</originalsourceid><addsrcrecordid>eNp9ktFrFDEQxoMotlZfffBBDgqiD3ed2SSbzeNxals88KWCbyHdzHa37CVnsiv0vzfL1bOVo2QgYfL7vjCTYewtwgKBV2c-etq2iwJQLWTxjB2jknouQf18vj-XeMRepXQLUJZCyZfsqKgElyjVMXt31dIs3aWBNl0983YYI81CM1t9-_yavWhsn-jN_X7Cfnz9crW6mK-_n1-ulut5LUs-zIlrhxY0l1o7rkVRKiUFls41QFg7TZqjKh2qwgI4KLXiorFCQC3huhH8hH3a-ba2N9vYbWy8M8F25mK5NlMOsBKVgOo3Zvbjjt3G8GukNJhNl2rqe-spjMlgpVFIWUiV0dP_0NswRp8rMRwFz93jOZ6gspfmObj-R93YnkznmzBEW09Pm6XQWPECFGRqcYDKy03NDZ6aLucfCT48ELRk-6FNoR-HLvh00LmOIaVIzb5PCGaaA7ObAzPNgZFFFry_L2u83pDb438_PgNnOyDlK39D8UHdhy3_AJGztmk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1899399339</pqid></control><display><type>article</type><title>The systemic nature of CKD</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Zoccali, Carmine ; Vanholder, Raymond ; Massy, Ziad A. ; Ortiz, Alberto ; Sarafidis, Pantelis ; Dekker, Friedo W. ; Fliser, Danilo ; Fouque, Denis ; Heine, Gunnar H. ; Jager, Kitty J. ; Kanbay, Mehmet ; Mallamaci, Francesca ; Parati, Gianfranco ; Rossignol, Patrick ; Wiecek, Andrzej ; London, Gerard</creator><creatorcontrib>Zoccali, Carmine ; Vanholder, Raymond ; Massy, Ziad A. ; Ortiz, Alberto ; Sarafidis, Pantelis ; Dekker, Friedo W. ; Fliser, Danilo ; Fouque, Denis ; Heine, Gunnar H. ; Jager, Kitty J. ; Kanbay, Mehmet ; Mallamaci, Francesca ; Parati, Gianfranco ; Rossignol, Patrick ; Wiecek, Andrzej ; London, Gerard ; European Renal and Cardiovascular Medicine (EURECA-m) Working Group of the European Renal Association – European Dialysis Transplantation Association (ERA-EDTA) ; on behalf of the European Renal and Cardiovascular Medicine (EURECA-m) Working Group of the European Renal Association – European Dialysis Transplantation Association (ERA-EDTA)</creatorcontrib><description>Key Points CKD is an inherently systemic disease Energy balance, innate immunity and neuroendocrine control of organ function are highly integrated biological processes; such integration is disrupted by loss of kidney function, which generates a high risk clinical phenotype The clinical profile of chronic kidney disease (CKD) includes inflammation, malnutrition, altered activity of the autonomic and central nervous systems, and cardiopulmonary, vascular and bone disease The gut and the lung are emerging as critical mediators of the interaction between the kidney and the environment, and are involved in cardiovascular disease and other systemic complications of CKD Alterations in macrovascular and microvascular function induced by sleep apnoea, inflammation and oxidative stress increase the risk of brain disease in CKD The application of omics sciences will enable in-depth studies of the pathophysiology and treatment of CKD Chronic kidney disease (CKD) affects numerous organs and systems, which in turn have effects on kidney function. This Review provides an overview of CKD as a systemic disease and discusses the multidirectional links between the kidney, bone, nervous and immune systems, and metabolism. The accurate definition and staging of chronic kidney disease (CKD) is one of the major achievements of modern nephrology. Intensive research is now being undertaken to unravel the risk factors and pathophysiologic underpinnings of this disease. In particular, the relationships between the kidney and other organs have been comprehensively investigated in experimental and clinical studies in the last two decades. Owing to technological and analytical limitations, these links have been studied with a reductionist approach focusing on two organs at a time, such as the heart and the kidney or the bone and the kidney. Here, we discuss studies that highlight the complex and systemic nature of CKD. Energy balance, innate immunity and neuroendocrine signalling are highly integrated biological phenomena. The diseased kidney disrupts such integration and generates a high-risk phenotype with a clinical profile encompassing inflammation, protein–energy wasting, altered function of the autonomic and central nervous systems and cardiopulmonary, vascular and bone diseases. A systems biology approach to CKD using omics techniques will hopefully enable in-depth study of the pathophysiology of this systemic disease, and has the potential to unravel critical pathways that can be targeted for CKD prevention and therapy.</description><identifier>ISSN: 1759-5061</identifier><identifier>ISSN: 1759-507X</identifier><identifier>EISSN: 1759-507X</identifier><identifier>DOI: 10.1038/nrneph.2017.52</identifier><identifier>PMID: 28435157</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/4022/1585/104 ; 692/698/1543/1565 ; 692/699/1670/316 ; 692/699/75 ; Amino acids ; Animals ; Biomarkers ; Bone Diseases - etiology ; Care and treatment ; Chronic kidney failure ; Development and progression ; Diagnosis ; Energy ; Energy Metabolism ; Energy storage ; Epidemiology ; Glucose ; Heart Diseases - etiology ; Hemodialysis ; Homeostasis ; Hormones ; Hospitals ; Humans ; Hypertension ; Immune system ; Immunity ; Immunity (Disease) ; Inflammation ; Inflammation - etiology ; Insulin resistance ; Internal medicine ; Kidney diseases ; Life Sciences ; Lung Diseases - etiology ; Medicine ; Medicine &amp; Public Health ; Metabolic Diseases - etiology ; Metabolism ; Nephrology ; Nervous System Diseases - etiology ; Pathophysiology ; Renal Insufficiency, Chronic - complications ; Renal Insufficiency, Chronic - immunology ; Renal Insufficiency, Chronic - metabolism ; review-article ; Systemic diseases ; Transplants &amp; implants</subject><ispartof>Nature reviews. Nephrology, 2017-06, Vol.13 (6), p.344-358</ispartof><rights>Springer Nature Limited 2017</rights><rights>COPYRIGHT 2017 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Jun 2017</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c563t-e39d1a093599d39426775416ddf0e1cd9e93176d172a00d069734fa440c50bf43</citedby><cites>FETCH-LOGICAL-c563t-e39d1a093599d39426775416ddf0e1cd9e93176d172a00d069734fa440c50bf43</cites><orcidid>0000-0002-9707-7199 ; 0000-0002-7212-2061</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/nrneph.2017.52$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/nrneph.2017.52$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28435157$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-01848408$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Zoccali, Carmine</creatorcontrib><creatorcontrib>Vanholder, Raymond</creatorcontrib><creatorcontrib>Massy, Ziad A.</creatorcontrib><creatorcontrib>Ortiz, Alberto</creatorcontrib><creatorcontrib>Sarafidis, Pantelis</creatorcontrib><creatorcontrib>Dekker, Friedo W.</creatorcontrib><creatorcontrib>Fliser, Danilo</creatorcontrib><creatorcontrib>Fouque, Denis</creatorcontrib><creatorcontrib>Heine, Gunnar H.</creatorcontrib><creatorcontrib>Jager, Kitty J.</creatorcontrib><creatorcontrib>Kanbay, Mehmet</creatorcontrib><creatorcontrib>Mallamaci, Francesca</creatorcontrib><creatorcontrib>Parati, Gianfranco</creatorcontrib><creatorcontrib>Rossignol, Patrick</creatorcontrib><creatorcontrib>Wiecek, Andrzej</creatorcontrib><creatorcontrib>London, Gerard</creatorcontrib><creatorcontrib>European Renal and Cardiovascular Medicine (EURECA-m) Working Group of the European Renal Association – European Dialysis Transplantation Association (ERA-EDTA)</creatorcontrib><creatorcontrib>on behalf of the European Renal and Cardiovascular Medicine (EURECA-m) Working Group of the European Renal Association – European Dialysis Transplantation Association (ERA-EDTA)</creatorcontrib><title>The systemic nature of CKD</title><title>Nature reviews. Nephrology</title><addtitle>Nat Rev Nephrol</addtitle><addtitle>Nat Rev Nephrol</addtitle><description>Key Points CKD is an inherently systemic disease Energy balance, innate immunity and neuroendocrine control of organ function are highly integrated biological processes; such integration is disrupted by loss of kidney function, which generates a high risk clinical phenotype The clinical profile of chronic kidney disease (CKD) includes inflammation, malnutrition, altered activity of the autonomic and central nervous systems, and cardiopulmonary, vascular and bone disease The gut and the lung are emerging as critical mediators of the interaction between the kidney and the environment, and are involved in cardiovascular disease and other systemic complications of CKD Alterations in macrovascular and microvascular function induced by sleep apnoea, inflammation and oxidative stress increase the risk of brain disease in CKD The application of omics sciences will enable in-depth studies of the pathophysiology and treatment of CKD Chronic kidney disease (CKD) affects numerous organs and systems, which in turn have effects on kidney function. This Review provides an overview of CKD as a systemic disease and discusses the multidirectional links between the kidney, bone, nervous and immune systems, and metabolism. The accurate definition and staging of chronic kidney disease (CKD) is one of the major achievements of modern nephrology. Intensive research is now being undertaken to unravel the risk factors and pathophysiologic underpinnings of this disease. In particular, the relationships between the kidney and other organs have been comprehensively investigated in experimental and clinical studies in the last two decades. Owing to technological and analytical limitations, these links have been studied with a reductionist approach focusing on two organs at a time, such as the heart and the kidney or the bone and the kidney. Here, we discuss studies that highlight the complex and systemic nature of CKD. Energy balance, innate immunity and neuroendocrine signalling are highly integrated biological phenomena. The diseased kidney disrupts such integration and generates a high-risk phenotype with a clinical profile encompassing inflammation, protein–energy wasting, altered function of the autonomic and central nervous systems and cardiopulmonary, vascular and bone diseases. A systems biology approach to CKD using omics techniques will hopefully enable in-depth study of the pathophysiology of this systemic disease, and has the potential to unravel critical pathways that can be targeted for CKD prevention and therapy.</description><subject>692/4022/1585/104</subject><subject>692/698/1543/1565</subject><subject>692/699/1670/316</subject><subject>692/699/75</subject><subject>Amino acids</subject><subject>Animals</subject><subject>Biomarkers</subject><subject>Bone Diseases - etiology</subject><subject>Care and treatment</subject><subject>Chronic kidney failure</subject><subject>Development and progression</subject><subject>Diagnosis</subject><subject>Energy</subject><subject>Energy Metabolism</subject><subject>Energy storage</subject><subject>Epidemiology</subject><subject>Glucose</subject><subject>Heart Diseases - etiology</subject><subject>Hemodialysis</subject><subject>Homeostasis</subject><subject>Hormones</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Immune system</subject><subject>Immunity</subject><subject>Immunity (Disease)</subject><subject>Inflammation</subject><subject>Inflammation - etiology</subject><subject>Insulin resistance</subject><subject>Internal medicine</subject><subject>Kidney diseases</subject><subject>Life Sciences</subject><subject>Lung Diseases - etiology</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Metabolic Diseases - etiology</subject><subject>Metabolism</subject><subject>Nephrology</subject><subject>Nervous System Diseases - etiology</subject><subject>Pathophysiology</subject><subject>Renal Insufficiency, Chronic - complications</subject><subject>Renal Insufficiency, Chronic - immunology</subject><subject>Renal Insufficiency, Chronic - metabolism</subject><subject>review-article</subject><subject>Systemic diseases</subject><subject>Transplants &amp; implants</subject><issn>1759-5061</issn><issn>1759-507X</issn><issn>1759-507X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9ktFrFDEQxoMotlZfffBBDgqiD3ed2SSbzeNxals88KWCbyHdzHa37CVnsiv0vzfL1bOVo2QgYfL7vjCTYewtwgKBV2c-etq2iwJQLWTxjB2jknouQf18vj-XeMRepXQLUJZCyZfsqKgElyjVMXt31dIs3aWBNl0983YYI81CM1t9-_yavWhsn-jN_X7Cfnz9crW6mK-_n1-ulut5LUs-zIlrhxY0l1o7rkVRKiUFls41QFg7TZqjKh2qwgI4KLXiorFCQC3huhH8hH3a-ba2N9vYbWy8M8F25mK5NlMOsBKVgOo3Zvbjjt3G8GukNJhNl2rqe-spjMlgpVFIWUiV0dP_0NswRp8rMRwFz93jOZ6gspfmObj-R93YnkznmzBEW09Pm6XQWPECFGRqcYDKy03NDZ6aLucfCT48ELRk-6FNoR-HLvh00LmOIaVIzb5PCGaaA7ObAzPNgZFFFry_L2u83pDb438_PgNnOyDlK39D8UHdhy3_AJGztmk</recordid><startdate>20170601</startdate><enddate>20170601</enddate><creator>Zoccali, Carmine</creator><creator>Vanholder, Raymond</creator><creator>Massy, Ziad A.</creator><creator>Ortiz, Alberto</creator><creator>Sarafidis, Pantelis</creator><creator>Dekker, Friedo W.</creator><creator>Fliser, Danilo</creator><creator>Fouque, Denis</creator><creator>Heine, Gunnar H.</creator><creator>Jager, Kitty J.</creator><creator>Kanbay, Mehmet</creator><creator>Mallamaci, Francesca</creator><creator>Parati, Gianfranco</creator><creator>Rossignol, Patrick</creator><creator>Wiecek, Andrzej</creator><creator>London, Gerard</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0002-9707-7199</orcidid><orcidid>https://orcid.org/0000-0002-7212-2061</orcidid></search><sort><creationdate>20170601</creationdate><title>The systemic nature of CKD</title><author>Zoccali, Carmine ; Vanholder, Raymond ; Massy, Ziad A. ; Ortiz, Alberto ; Sarafidis, Pantelis ; Dekker, Friedo W. ; Fliser, Danilo ; Fouque, Denis ; Heine, Gunnar H. ; Jager, Kitty J. ; Kanbay, Mehmet ; Mallamaci, Francesca ; Parati, Gianfranco ; Rossignol, Patrick ; Wiecek, Andrzej ; London, Gerard</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c563t-e39d1a093599d39426775416ddf0e1cd9e93176d172a00d069734fa440c50bf43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>692/4022/1585/104</topic><topic>692/698/1543/1565</topic><topic>692/699/1670/316</topic><topic>692/699/75</topic><topic>Amino acids</topic><topic>Animals</topic><topic>Biomarkers</topic><topic>Bone Diseases - etiology</topic><topic>Care and treatment</topic><topic>Chronic kidney failure</topic><topic>Development and progression</topic><topic>Diagnosis</topic><topic>Energy</topic><topic>Energy Metabolism</topic><topic>Energy storage</topic><topic>Epidemiology</topic><topic>Glucose</topic><topic>Heart Diseases - etiology</topic><topic>Hemodialysis</topic><topic>Homeostasis</topic><topic>Hormones</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Immune system</topic><topic>Immunity</topic><topic>Immunity (Disease)</topic><topic>Inflammation</topic><topic>Inflammation - etiology</topic><topic>Insulin resistance</topic><topic>Internal medicine</topic><topic>Kidney diseases</topic><topic>Life Sciences</topic><topic>Lung Diseases - etiology</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Metabolic Diseases - etiology</topic><topic>Metabolism</topic><topic>Nephrology</topic><topic>Nervous System Diseases - etiology</topic><topic>Pathophysiology</topic><topic>Renal Insufficiency, Chronic - complications</topic><topic>Renal Insufficiency, Chronic - immunology</topic><topic>Renal Insufficiency, Chronic - metabolism</topic><topic>review-article</topic><topic>Systemic diseases</topic><topic>Transplants &amp; implants</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zoccali, Carmine</creatorcontrib><creatorcontrib>Vanholder, Raymond</creatorcontrib><creatorcontrib>Massy, Ziad A.</creatorcontrib><creatorcontrib>Ortiz, Alberto</creatorcontrib><creatorcontrib>Sarafidis, Pantelis</creatorcontrib><creatorcontrib>Dekker, Friedo W.</creatorcontrib><creatorcontrib>Fliser, Danilo</creatorcontrib><creatorcontrib>Fouque, Denis</creatorcontrib><creatorcontrib>Heine, Gunnar H.</creatorcontrib><creatorcontrib>Jager, Kitty J.</creatorcontrib><creatorcontrib>Kanbay, Mehmet</creatorcontrib><creatorcontrib>Mallamaci, Francesca</creatorcontrib><creatorcontrib>Parati, Gianfranco</creatorcontrib><creatorcontrib>Rossignol, Patrick</creatorcontrib><creatorcontrib>Wiecek, Andrzej</creatorcontrib><creatorcontrib>London, Gerard</creatorcontrib><creatorcontrib>European Renal and Cardiovascular Medicine (EURECA-m) Working Group of the European Renal Association – European Dialysis Transplantation Association (ERA-EDTA)</creatorcontrib><creatorcontrib>on behalf of the European Renal and Cardiovascular Medicine (EURECA-m) Working Group of the European Renal Association – European Dialysis Transplantation Association (ERA-EDTA)</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Nature reviews. Nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zoccali, Carmine</au><au>Vanholder, Raymond</au><au>Massy, Ziad A.</au><au>Ortiz, Alberto</au><au>Sarafidis, Pantelis</au><au>Dekker, Friedo W.</au><au>Fliser, Danilo</au><au>Fouque, Denis</au><au>Heine, Gunnar H.</au><au>Jager, Kitty J.</au><au>Kanbay, Mehmet</au><au>Mallamaci, Francesca</au><au>Parati, Gianfranco</au><au>Rossignol, Patrick</au><au>Wiecek, Andrzej</au><au>London, Gerard</au><aucorp>European Renal and Cardiovascular Medicine (EURECA-m) Working Group of the European Renal Association – European Dialysis Transplantation Association (ERA-EDTA)</aucorp><aucorp>on behalf of the European Renal and Cardiovascular Medicine (EURECA-m) Working Group of the European Renal Association – European Dialysis Transplantation Association (ERA-EDTA)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The systemic nature of CKD</atitle><jtitle>Nature reviews. Nephrology</jtitle><stitle>Nat Rev Nephrol</stitle><addtitle>Nat Rev Nephrol</addtitle><date>2017-06-01</date><risdate>2017</risdate><volume>13</volume><issue>6</issue><spage>344</spage><epage>358</epage><pages>344-358</pages><issn>1759-5061</issn><issn>1759-507X</issn><eissn>1759-507X</eissn><abstract>Key Points CKD is an inherently systemic disease Energy balance, innate immunity and neuroendocrine control of organ function are highly integrated biological processes; such integration is disrupted by loss of kidney function, which generates a high risk clinical phenotype The clinical profile of chronic kidney disease (CKD) includes inflammation, malnutrition, altered activity of the autonomic and central nervous systems, and cardiopulmonary, vascular and bone disease The gut and the lung are emerging as critical mediators of the interaction between the kidney and the environment, and are involved in cardiovascular disease and other systemic complications of CKD Alterations in macrovascular and microvascular function induced by sleep apnoea, inflammation and oxidative stress increase the risk of brain disease in CKD The application of omics sciences will enable in-depth studies of the pathophysiology and treatment of CKD Chronic kidney disease (CKD) affects numerous organs and systems, which in turn have effects on kidney function. This Review provides an overview of CKD as a systemic disease and discusses the multidirectional links between the kidney, bone, nervous and immune systems, and metabolism. The accurate definition and staging of chronic kidney disease (CKD) is one of the major achievements of modern nephrology. Intensive research is now being undertaken to unravel the risk factors and pathophysiologic underpinnings of this disease. In particular, the relationships between the kidney and other organs have been comprehensively investigated in experimental and clinical studies in the last two decades. Owing to technological and analytical limitations, these links have been studied with a reductionist approach focusing on two organs at a time, such as the heart and the kidney or the bone and the kidney. Here, we discuss studies that highlight the complex and systemic nature of CKD. Energy balance, innate immunity and neuroendocrine signalling are highly integrated biological phenomena. The diseased kidney disrupts such integration and generates a high-risk phenotype with a clinical profile encompassing inflammation, protein–energy wasting, altered function of the autonomic and central nervous systems and cardiopulmonary, vascular and bone diseases. A systems biology approach to CKD using omics techniques will hopefully enable in-depth study of the pathophysiology of this systemic disease, and has the potential to unravel critical pathways that can be targeted for CKD prevention and therapy.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>28435157</pmid><doi>10.1038/nrneph.2017.52</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0002-9707-7199</orcidid><orcidid>https://orcid.org/0000-0002-7212-2061</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1759-5061
ispartof Nature reviews. Nephrology, 2017-06, Vol.13 (6), p.344-358
issn 1759-5061
1759-507X
1759-507X
language eng
recordid cdi_hal_primary_oai_HAL_hal_01848408v1
source MEDLINE; Springer Nature - Complete Springer Journals
subjects 692/4022/1585/104
692/698/1543/1565
692/699/1670/316
692/699/75
Amino acids
Animals
Biomarkers
Bone Diseases - etiology
Care and treatment
Chronic kidney failure
Development and progression
Diagnosis
Energy
Energy Metabolism
Energy storage
Epidemiology
Glucose
Heart Diseases - etiology
Hemodialysis
Homeostasis
Hormones
Hospitals
Humans
Hypertension
Immune system
Immunity
Immunity (Disease)
Inflammation
Inflammation - etiology
Insulin resistance
Internal medicine
Kidney diseases
Life Sciences
Lung Diseases - etiology
Medicine
Medicine & Public Health
Metabolic Diseases - etiology
Metabolism
Nephrology
Nervous System Diseases - etiology
Pathophysiology
Renal Insufficiency, Chronic - complications
Renal Insufficiency, Chronic - immunology
Renal Insufficiency, Chronic - metabolism
review-article
Systemic diseases
Transplants & implants
title The systemic nature of CKD
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T13%3A55%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20systemic%20nature%20of%20CKD&rft.jtitle=Nature%20reviews.%20Nephrology&rft.au=Zoccali,%20Carmine&rft.aucorp=European%20Renal%20and%20Cardiovascular%20Medicine%20(EURECA-m)%20Working%20Group%20of%20the%20European%20Renal%20Association%20%E2%80%93%20European%20Dialysis%20Transplantation%20Association%20(ERA-EDTA)&rft.date=2017-06-01&rft.volume=13&rft.issue=6&rft.spage=344&rft.epage=358&rft.pages=344-358&rft.issn=1759-5061&rft.eissn=1759-507X&rft_id=info:doi/10.1038/nrneph.2017.52&rft_dat=%3Cgale_hal_p%3EA491832070%3C/gale_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1899399339&rft_id=info:pmid/28435157&rft_galeid=A491832070&rfr_iscdi=true